Carregant...
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
Mineralocorticoid-receptor antagonists (MRAs) have proven to be effective in some types of hypertension, especially in resistant hypertension (RHTN). In this phenotype of hypertension, the renin–angiotensin–aldosterone pathway plays an important role, with MRAs being especially effective in reducing...
Guardat en:
| Publicat a: | Vasc Health Risk Manag |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652936/ https://ncbi.nlm.nih.gov/pubmed/29081661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S138599 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|